Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
irrespective of PD-L1 expression level or tumor histology. Although cervical cancer is often curable when detected early and effectively managed, advanced or metastatic disease – when the cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results